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Abstract 
CO2 infusion of biomolecules is a benign, green, and inexpensive method to provide 
much-needed biochemical activity to electrospun nanofibers for tissue engineering 
applications.  This study investigated the effects of hydrophobic-hydrophilic interactions 
on dual drug release from CO2-infused nanofibers (PCL, PCL-gelatin, and PCL ‘core’ 
PCL-gelatin ‘shell’) using BODIPY 493/503 and Rhodamine B fluorescent dyes as drug 
models.  Interestingly, when exposed to supercritical CO2, core-shell fibers did not melt.  
Positive dye-matrix interactions led to increased dye loading and gradual, linear release.  
Conversely, the opposite was observed for negative interactions.  When two dyes were 
infused, this behavior was accentuated due to interactions between dyes. CO2 infusion, 
without changing scaffold microstructure, positively impacted both dye loading and 
longer-term release when individual dyes were infused into scaffolds of unlike polarity.  
Core-shell nanofibers displayed radically different release properties versus PCL-gelatin 
when treated with dyes via CO2 infusion.  Dye release from core-shell scaffolds was 
highly sensitive to both interactions with scaffolds and phase of CO2. By using different 
phases of CO2 to partition dyes into hydrophobic and hydrophilic sections of core-shell 
nanofiber scaffolds, interactions can be manipulated to develop a bimodal drug release 
system.   
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1 Introduction 
Biomimetic materials, both synthetic and natural, have been applied as wound 
dressings to accelerate the healing process. In early efforts alginate, a compound derived 
from seaweed, was used as the basis for wound dressings [1,2]. Other natural polymers 
including collagen, fibrin, chitosan, and even xenograft dermis have been investigated 
and utilized for their ability to interact favorably with cells at the wound site and provide 
a biological microstructure mimicking the extracellular matrix (ECM) of human tissues 
[3-8].  In contrast, synthetic polymers have a distinct advantage in that they are easily 
tailored for a specific application, providing an engineered alternative with control over 
properties such as modulus and degradation rate [9-11]. Biocompatible polymers such as 
polyglycolic acid (PGA), polylactic acid (PLA), polyurethane (PU), and polycaprolactone 
(PCL) see widespread use in wound healing and tissue engineering applications [9,12-
14].  However, a shortcoming of these synthetic materials lies in their inherently limited 
biofunctionality.  Electrospinning is a polymer processing technique that has been used to 
produce nano-scale diameter fibers from all of these synthetics, providing a high surface-
area substrate resembling the microstructure and morphology of native ECM, which is 
attractive for regenerative medicine applications [9,12-17].  Bioactivity is often further 
augmented with methods to incorporate drugs or growth factors. 
To further these goals, investigators have applied many different techniques of 
biofunctionalization to electrospun nanofibers, including adhesion treatments, surface 
coupling of biomolecules, and drug infusion into the polymer bulk [17-21].  In particular, 
controlled release of incorporated drugs is an expanding area of research, due to the 
enormous potential to affect biologic sites via spatiotemporal differences in drug 
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application [22].  Approaches for control include diffusion barrier manipulation, tailored 
solvent swelling, chemical degradation, and actuation of external stimuli such as 
magnetic fields or heat [21].  While in some cases effective, these methods can prove 
challenging to control and often lead to deleterious effects on nanofiber morphology or 
drug bioactivity [23].  Supercritical fluids technology utilizes the phase transition of 
carbon dioxide to provide an effective means of drug incorporation and release from 
nanofiber scaffolds via precise control of drug impregnation with experimental pressure 
and temperature of CO2 [24]. Previous studies have established both supercritical and 
subcritical CO2 infusion as benign, green, and inexpensive techniques that can be used to 
biofunctionalize nanofiber scaffolds [24-26]. 
In this context, chronic wounds are a specific type of condition that, due to a 
malfunction in the natural healing process, can take years to heal and in some cases may 
not heal at all.  This results in long term pain, persistent infection, and lengthy 
hospitalizations [27].  These wounds affect nearly 6.5 million patients in the United 
States alone, resulting in a yearly medical expenditure of $25 billion [27].  The biological 
causes of aberrancy in chronic wounds are quite complex. Therefore, recent engineering 
approaches to scaffold design for this application frequently incorporate multiple drugs 
into a single scaffold [22,28-31]. Thus, controlled release has become increasingly 
important as interactions between these drugs as well as interactions between the drugs 
and scaffold must be elucidated.  Hydrophobic-hydrophilic interactions are a factor 
playing a prominent role in diffusion-based release [21].  Several studies have proposed 
these interactions as possible causes for observed release behavior but few have 
investigated and quantified the effect of such interactions on release [29,30,32].  To make 
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progress toward the goal of an electrospun nanofiber scaffold having multiple drug 
functionalizations realized by CO2 infusion, this study aims to investigate the effects that 
hydrophobic-hydrophilic match and mismatch have on the loading and release of drugs 
infused into electrospun nanofibers via supercritical or subcritical CO2 exposure. 
Drugs were modeled in this study using two different fluorescent dyes.  
Rhodamine B ([9-(2-carboxyphenyl)-6-diethylamino-3-xanthenylidene]- 
diethylammonium chloride) was used as a model hydrophilic drug, while BODIPY 
493/503 (4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-propionic 
acid) was utilized as a model hydrophobic drug.  PCL was used as a hydrophobic scaffold 
and a 50:50 PCL-Gelatin blend as a hydrophilic scaffold.  Dyes were infused into each 
scaffold in a variety of hydrophobicity match-mismatch conditions via supercritical 
and/or subcritical CO2.  Infusion by simple adsorption was used as a control.  Release of 
dye over two weeks and the initial dye loading were measured to investigate and quantify 
the effects of drug-matrix interactions on controlled release.  Visual observation of 
scaffolds before and after release was also used to draw qualitative conclusions. This 
study aims to improve understanding of polarity-based drug-drug and drug-matrix 
interactions within a dual infusion and release system.  This understanding will enable the 
development of tightly controlled multi-drug release from CO2 infused nanofiber 
scaffolds to better modulate complex regenerative medicine challenges such as chronic 
wound healing. 
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2 Materials and Methods 
2.1 Polymer and dye solutions 
Five wt.% polycaprolactone (PCL) (Sigma-Aldrich, St. Louis, MO; Mn 70-90 
KDa) and 6.7 wt.% type A porcine gelatin (300 Bloom; Sigma-Aldrich, St. Louis, MO) 
solutions were produced by dissolution in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) 
(Oakwood Chemical, West Columbia, SC) at room temperature (~25oC) for 24 hours 
with magnetic stirring.  Initially separate solutions of PCL and gelatin were mixed in 
equal parts by volume and the combination stirred at room temperature (~25oC) for 24 
hours to create a hydrophilic blend.  Pure PCL solution was used as a hydrophobic 
polymer.   Solutions containing 0.1 mg/mL of Rhodamine B (Standard Fluka; Sigma-
Aldrich, St. Louis, MO) and 0.1 mg/mL of BODIPY 493/503 (Life Technologies, 
Carlsbad, CA) were dissolved separately in 200 proof ethanol (Hedwin, Baltimore, MD).  
Dual dye solutions containing both 0.1 mg/mL Rhodamine B and 0.1 mg/mL BODIPY 
were also produced.  Stirring at room temperature for 24 hours was necessary to dissolve 
BODIPY in ethanol solution.  Both dye solutions were protected from photobleaching by 
wrapping the solution containers in aluminum foil and storing them in the dark when not 
in use. 
2.2 Electrospinning 
Solutions of PCL-gelatin blend and pure PCL were poured into 60 mL syringes, 
fitted with an 18 gage blunt tip needle, and mounted onto a syringe pump (kdScientific, 
Holliston, MA).  Solutions were electrospun into 7.5 x 7.5 cm nanofiber sheets using a 
DC high voltage power supply (Glassman High Voltage, High Bridge, NJ) at 20 kV and a 
cathode to anode separation of 21 cm [33].  Flow rates and electrospinning time were 
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adjusted to ensure good fiber production, as shown in the SEM, and 10 mL of polymer 
solution was required to fabricate each scaffold.  ‘Core-shell’ nanofibers were produced 
using a concentric needle attachment wherein PCL solution flowed through the center 
needle while PCL-gelatin solution flowed through a larger diameter needle surrounding it 
[34].  The previously listed electrospinning parameters were used for core-shell samples 
as well.  The core to shell flow rate ratio was established at 1:4.  16 mm diameter disc 
samples were removed from as-produced nanofiber sheets using a metal arc punch (CS 
Osborn & Co, Harrison, NJ) and weighed.  Only discs with weights between 20 and 30 
mg were included in the study. 
2.3 Dye Infusion 
Disc samples were placed on a sheet of aluminum foil in a chemical fume hood.  
500 μL of .1 mg/mL dye solution was adsorbed onto each scaffold in 100 μL increments; 
10 minutes separated each application.  Samples were allowed to dry at room temperature 
for 24 hours in the fume hood before infusion.  The control scaffolds received no other 
infusion treatment but simple adsorption.  Experimental scaffolds were lightly wrapped in 
aluminum foil and inserted into a stainless steel vessel for CO2 infusion.  CO2 (Praxair, 
Columbus, OH) was compressed via a 1015 mL syringe pump (Teledyne ISCO, Lincoln, 
NE) to high pressures within the vessel.  Scaffolds were exposed for 2 h to either 
subcritical CO2 at 6.20 MPa at 25oC or supercritical CO2 at 8.27 MPa at 40oC.  After 
infusion, the vessel was depressurized slowly overnight.  Temperature was maintained 
using a thermocouple system incorporated into the pressure vessel apparatus.  Upon 
removal from the vessel, samples were rinsed within separate 15 mL vials with 70% 
ethanol in water for 30 minutes.  Following rinsing, scaffolds were dried overnight in a 
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chemical fume hood and placed into fresh vials covered in aluminum foil.   Dye loading 
was defined as the amount of dye remaining within the scaffold following the ethanol 
wash step. 
2.4 Dye release 
Scaffolds were soaked in 1 mL phosphate buffered saline (PBS) (AMRESCO, 
Solon, OH) plus 0.1 wt.% sodium azide (Sigma Aldrich, St. Louis, MO).  At specified 
time points over the course of 2 weeks, the PBS was removed from each vial, stored in a 
1.5 mL microcentrifuge tube (FisherBrand, Florence, KY), and replaced with 1 mL of 
fresh PBS.  Aliquots of collected dye samples were placed into polystyrene 96 well plates 
(FisherBrand, Florence, KY) and analyzed with a fluorescence spectrophotometer 
(Spectra Max 190, Sunnyvale, CA) against a serial dilution of known dye concentrations. 
2.5 Sample degradation 
To quantify the dye retained by the sample after release was completed, each 16 
mm disc was dissolved in 5 mL of HFP over 72 hours with 2 minutes of initial vortexing 
(VWR Vortex, VWR International, Radnor, PA).  Degradation solutions were diluted by 
a factor of 5 in HFP.  Aliquots of the diluted solutions were placed into polypropylene 96 
well plates (FisherBrand, Florence, KY) and immediately analyzed with a fluorescence 
spectrophotometer against known dye concentrations.  Loading values were acquired by 
summing the amount of dye released by degradation with the total amount of dye 
collected during the release process. 
2.6 Scanning electron microscopy 
Morphological changes before and after CO2 exposure were analyzed using SEM.  
As spun samples, subcritical post-infusion samples, and supercritical post-infusion 
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samples were adhered to aluminum studs using carbon tape (Ted Pella, Reading, CA) and 
sputter-coated under argon gas with a 15 nm layer of Au-Pd (Pelco Model 3 sputter 
coater 91000, USA) at an emission current of 15 mA.  Samples were examined by SEM 
(Quanta 300, Netherlands) allowing microstructural characterization at an accelerating 
voltage of 12 kV.   
2.7 X-Ray diffraction 
To measure changes in crystallinity following infusion, X-ray diffraction (XRD) 
(Ultima III, Rigaku Inc., Japan) utilizing a Cu X-ray source (40 kV) was conducted on 
samples before and after CO2 infusion [35]. 22 mm diameter punches were removed 
from as spun PCL and core-shell nanofiber sheets and subjected to XRD analysis.  The 
PCL punch was then subjected to subcritical infusion and the core-shell punch was 
subjected to supercritical infusion.  Both samples were again analyzed using XRD over 
the range of 20-30o 2θ.  
2.8 Contact angle testing 
Hydrophobicity of the different scaffolds was analyzed by contact angle 
measurement.  Samples of PCL, PCL-gelatin, and core-shell nanofiber scaffolds were 
analyzed using a sessile drop method on an Easy Drop goniometer (Kruess, Hamburg, 
Germany).  400 μL of deionized water was placed onto the scaffold as a single drop and a 
screenshot taken after 3 seconds.  Easy Drop software was utilized to calculate a contact 
angle based on the screenshot.  Five measurements were taken for each type of scaffold 
and averaged. 
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2.9 Image analysis 
Changes in the color of the punched samples over the course of release were 
visible to the naked eye.  Representative images of PCL and PCL-gelatin infused with 
both dyes before and after the two week release process were taken using a bright field 
camera.   
3 Results 
3.1 Fiber morphology and microstructure 
 Electrospun nanofibers were imaged via SEM to observe their highly porous and 
fibrous microstructure. Figure 1 displays the SEM images of pre- (A-C) and post-CO2 
exposed (D-F) electrospun PCL, PCL-gelatin, and PCL ‘core’ PCL-gelatin ‘shell’ 
nanofibers. The unique microstructure of electrospun nanofiber provides a dense fibrous 
matrix closely resembling that of native tissue’s extracellular matrix, especially the >80% 
porosity. Figure 1 (A,D) shows PCL fibers that are uniform, continuous, and free of 
beads or fiber-fiber bonds. Post-exposure to subcritical CO2, only minor fiber-fiber 
bonding occurs without changes to the overall microstructure of the matrix or 
morphology of the fibers. PCL-gelatin nanofibers (Figure 1 (B,E)) pre- and post-
subcritical CO2 display no significant difference in microstructure or morphology as a 
result of exposure.  Results from previous work have shown that supercritical conditions 
can result in significant alterations to PCL nanofiber microstructure and morphology 
resulting in a nearly film-like final state [24,35]. Interestingly, PCL ‘core’ PCL-gelatin 
‘shell’ nanofibers display intact microstructure and porosity post-supercritical CO2 
exposure (Figure 1 (C,F)), suggesting that the PCL-gelatin shell has enough interaction 
with the pure PCL core to shield or protect it from CO2-driven morphological alteration. 
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 Figure 1:  Scanning electron microscope images of untreated (A,B,C) and treated (D,E,F) PCL, PCL-
gelatin, and PCL ‘core’ PCL-gelatin ‘shell’ nanofiber scaffolds, respectively.  PCL and PCL-gelatin 
scaffolds were treated with subcritical (6.20 MPa, 25°C) CO2 and core-shell scaffolds were treated with 
supercritical (8.27 MPa, 37°C) CO2.  All scaffolds retain clear nanofiber morphology after CO2 exposure. 
 
 
 
 
A)  PCL untreated  D)  PCL subcritical 
B)  PCL-gelatin untreated  E)  PCL-gelatin subcritical  
C)  core-shell untreated  F)  core-shell supercritical 
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3.1.1 X-ray diffraction analysis 
X-ray diffraction spectra (Figure 2) further imply that subcritical and supercritical 
CO2 exposures do not cause significant alterations in the microstructure of PCL and core-
shell nanofiber scaffolds, respectively.  Interestingly, PCL and core-shell samples both 
show slight increases in intensity of the characteristic PCL crystal peaks (at  21.5 and 24° 
2θ) following infusion.   
 
Figure 2:  X-ray diffraction data from PCL and PCL ‘core’ PCL-gelatin ‘shell’ fibers pre- and 
post-infusion.  Pure PCL fibers were infused subcritically at 6.20 MPa and 25°C while core-shell 
fibers were infused supercritically at 8.27 MPa and 40°C.  An increase in intensity of 
characteristic PCL peaks at 21.5 and 24° 2θ post-infusion can be seen. 
 
3.1.2 Contact angle testing 
Contact angle experiments were used to validate the hypothesis that PCL 
constitutes a hydrophobic polymer and a 50:50 PCL-gelatin blend constitutes a 
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hydrophilic polymer.  It was found that PCL had a wetting angle of 126.16 +/- 14.74 
degrees.  PCL-gelatin displayed a wetting angle of 0 degrees immediately after water 
droplets were placed onto it.  By definition, PCL is considered hydrophobic and PCL-
gelatin is considered hydrophilic.  
3.2 Dye release behavior 
 Figure 3 displays an optical image of the electrospun nanofiber samples, initially 
saturated with equal concentrations of both BODIPY and Rhodamine B fluorescent dye, 
before and after release. Both the PCL and PCL-gelatin scaffolds (Figure 3 (A,B)) are 
dyed a similar red-purple color before release.  Post-release images (Figure 3 (C,D)) 
show the color of the scaffolds with residual dye present after 334 hours of release.  
 
Figure 3: Visual appearance of PCL and PCL-gelatin after (A,B) subcritical CO2 infusion of 
BODIPY+Rhodamine B at 6.20 MPa and 25°C and after (C,D) 334 hours of release in PBS.  Scaffolds 
both appear a reddish-purple color before release.  Post-release, PCL adopts the green color of BODIPY 
dye while PCL-gelatin is predominantly red in color, a characteristic of Rhodamine B dye. 
A) PCL: after 
infusion 
D) PCL-gelatin: after 
infusion/release 
C) PCL: after 
infusion/release 
B) PCL-gelatin: 
after infusion 
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PCL nanofiber scaffolds assume a yellow-green color post-release; PCL-gelatin appears 
have an orange-red tint post-release. This significant difference in color post-release 
confirms that BODIPY has a high affinity for PCL due to like hydrophobic interactions 
and that Rhodamine B has a high affinity to PCL-gelatin due to like hydrophilic 
interactions with the gelatin.  Rhodamine in PCL and BODIPY in PCL-gelatin have been 
substantially released over the 334 hours due to unlike interactions. 
Plots of release versus time confirm the optical observations (Figure 3), suggesting that 
hydrophobic-hydrophilic interactions can play a significant role in the release behaviors 
of the two different dyes. Figure 4 displays the percentage of total BODIPY (A) or 
Rhodamine B (B) released from PCL and from PCL-gelatin nanofiber scaffolds. 
BODIPY (Figure 4(A)) displays no significant difference in release percentage for 
adsorption-treated PCL or PCL-gelatin scaffolds, however significant differences in the 
release behavior and percentage of dye released are observed for nanofiber scaffolds 
treated with subcritical 6.20 MPa CO2-assisted infusion. Subcritically-infused BODIPY 
PCL samples release 2.5% of their total loading, while PCL-gelatin releases 3.5%. The 
release behavior for subcritically infused BODIPY from PCL or PCL-gelatin scaffolds 
displayed an initial burst release (likely due to residual surface adsorbed dye), followed 
by linear release kinetics driven by diffusion. Rhodamine B release from PCL or PCL-
gelatin scaffolds (Figure 4(B)) displays significant burst release kinetics for adsorbed 
PCL and PCL-gelatin for early time points. Subcritically infused PCL and PCL-gelatin 
showed similar burst release profiles until 72 hours, at which point release from PCL-
gelatin continued while release from PCL stagnated.  Adsorbed Rhodamine B exhibited 
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Figure 4:  Release of A) BODIPY and B) Rhodamine B represented as a percent of initial scaffold loading 
following infusion of a single dye into PCL or PCL-gelatin.  Total initial loading in ng is also given and is 
defined as the amount of dye in the scaffold after infusion and a 30 minute wash in 70% ethanol.  Error 
bars represent one standard deviation in both directions.  Colored circle in picture shows hypothesized dye 
localization in a fiber cross-section based on infusion condition. 
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nearly two-fold release from PCL scaffolds compared to PCL-gelatin, further illustrating 
favorable hydrophilic interactions between Rhodamine B and gelatin.  No significant 
difference in the percentage released of total loaded Rhodamine B was observed between 
adsorption on PCL-gelatin and subcritical infusion on PCL or PCL-gelatin. However, in 
terms of amount of dye released, subcritically infused PCL-gelatin scaffolds released 
~9000 ng of dye, statistically greater than all other conditions.  Rhodamine B adsorption-
treated PCL scaffolds released 84% of total loaded content within 24 hours, while PCL 
scaffolds treated with Rhodamine B by subcritical infusion released only 45% of their 
total content in this time.  
Figure 5 displays the release of BODIPY (A) and Rhodamine B (B) from PCL 
and PCL-gelatin scaffolds treated with both dyes in equal concentrations via subcritical 
CO2 or simple adsorption.  BODIPY (Figure 5(A)) displays very little difference from 
single dye infusion (Figure 4(A)) in terms of percentage of dye released or release 
behavior. However, significant differences are noticed in Rhodamine B release when 
both dyes are present (Figure 5(B)). The release of subcritically infused Rhodamine B 
from PCL (unlike condition) increased by 20% over single dye-infused scaffolds, while 
release of subcritically infused Rhodamine B from PCL-gelatin (like condition) decreased 
by 40% compared to single dye conditions (Figure 4 (B)). This suggests that the goal of 
greater retention of ‘like’ dye and greater release of ‘unlike’ dye within a dual-dye system 
has been achieved.  Furthermore, these results are evidence of competitive interaction 
between multiple dyes during the infusion and release process.  No significant difference 
in the percentage of Rhodamine B released from adsorption-treated scaffolds was 
observed between single and dual dye infusion conditions (Figures 4(B) and 5(B)).   
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Figure 5:  Release of A) BODIPY and B) Rhodamine B represented as a percent of initial scaffold loading 
following simultaneous infusion of both dyes into either PCL or PCL-gelatin. Initial loading in ng is also 
given.  Release of Rhodamine B from PCL following subcritical CO2 infusion is nearly twice that observed 
in Figure 4 (B), suggesting that addition of BODIPY to scaffold causes increased release of Rhodamine B.  
Error bars represent one standard deviation in both directions.  Colored circle in picture shows 
hypothesized dye localization in a fiber cross-section based on infusion condition (purple = mixed). 
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 Furthermore, for both BODIPY and Rhodamine B, core-shell scaffolds treated with both 
dyes (Figure 6(A,B)) using simple adsorption displayed release percentages statistically 
similar to PCL-gelatin scaffolds treated with adsorption of one or both dyes. These 
findings suggest that release of adsorbed drugs is statistically unaffected by infusion of 
additional dyes or use of composite scaffolds.  
Figure 6(A) shows that, within PCL ‘core’ PCL-gelatin ‘shell’ scaffolds, 
supercritical infusion of BODIPY causes slower release compared to BODIPY infused 
under subcritical conditions. This trend is opposite that for Rhodamine B infused 
scaffolds, displaying increased release percentages for supercritically infused scaffolds as 
compared to subcritically infused nanofiber scaffolds.  These observations suggest that 
supercritically infused BODIPY and subcritically infused Rhodamine B are experiencing 
favorable interactions with the scaffold, while subcritically infused BODIPY and 
supercritically infused Rhodamine B are experiencing unfavorable interactions.  
Therefore, high penetration supercritical infusion likely infuses dye into the hydrophobic 
core while lower penetration subcritical infusion likely infuses dye into the hydrophilic 
shell.   
21 
 
  
Figure 6:  Release of A) BODIPY and B) Rhodamine B represented as a percent of initial scaffold loading 
following infusion into PCL ‘core’ PCL-gelatin ‘shell’ nanofibers using either subcritical infusion, 
supercritical infusion, or simple adsorption conditions.  Initial loading in ng is also given.  The percentage 
release following adsorption is very similar to that of Figure 5 as anticipated given that the exterior surface 
of the nanofiber is identical.  Error bars represent one standard deviation in both directions.  Colored circle 
in picture shows hypothesized dye localization in a fiber cross-section based on infusion condition. 
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3.3. Dye infusion and loading analysis  
 To further corroborate evidence of the effects that hydrophobic-hydrophilic 
interactions have on drugs infused into nanofiber scaffolds via CO2, differential loading 
of dyes was also quantified. Figure 7(A) displays the total loaded BODIPY content in 
PCL or PCL-gelatin nanofiber scaffolds treated using either subcritical CO2 or simple 
adsorption. Subcritical CO2 infusion of BODIPY into PCL or PCL-gelatin scaffolds 
displayed significantly greater loading than adsorption, amounting to approximately a 
30% increase. No significant differences in loading were observed between PCL and 
PCL-gelatin scaffolds (Figure 7(A)). Similar trends were observed for BODIPY loading 
when both dyes were infused into PCL or PCL-gelatin scaffolds, resulting in a net 45% 
increase over simple adsorption. No significant differences were observed in the loading 
of BODIPY between single and dual dye adsorption. Figure 7(B) shows that supercritical 
infusion resulted in no significant differences in loading compared to adsorption.  
Subcritical infusion of BODIPY resulted in a 33% increase in loading compared to 
adsorption. Loading of Rhodamine B into PCL or PCL-gelatin scaffolds (Figure 8(A)) 
and into core-shell samples (Figure 8(B)) further showed that significant improvements 
in loading were achieved when CO2 infusion was utilized over adsorption. Subcritical 
CO2 infusion resulted in nearly 2-fold increases in Rhodamine B loading compared to 
adsorption on hydrophilic PCL-gelatin. Nearly a 3-fold increase in loading over 
adsorption was achieved for Rhodamine B infused into hydrophobic PCL nanofibers by 
subcritical CO2. Similar trends were observed for core-shell scaffolds (Figure 8(B)), 
showing a significant increase in loading for supercritical and subcritical infusion of 
Rhodamine B over simple adsorption.    
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 Figure 7: A) Absolute BODIPY loading into either PCL or PCL-gelatin. Subcritical CO2 exposure 
increases dye loading over simple adsorption by ~50% for PCL and ~30% for PCL-gelatin.  B) Absolute 
BODIPY loading into PCL ‘core’ PCL-gelatin ‘shell’ nanofibers under subcritical (6.20 MPa, 25°C) and  
supercritical (8.27 MPa, 40°C) CO2 conditions versus simple adsorption at 25°C.  The schematic in the 
figure displays the cross-section of a core-shell fiber. Supercritical CO2 exposure does not result in any 
statistical difference of BODIPY loading into these scaffolds compared to adsorption. *Significantly 
different from adsorption condition (p <.05). 
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Figure 8:   A) Absolute Rhodamine B loading into either PCL or PCL-gelatin under subcritical CO2 
conditions versus simple adsorption at 25°C. Subcritical CO2 exposure increases dye loading over simple 
adsorption by ~300% for PCL and ~200% for PCL-gelatin.  B) Absolute Rhodamine B loading into PCL 
‘core’ PCL-gelatin ‘shell’ nanofibers under subcritical (6.2MPa, 25°C)  and  supercritical (8.27 MPa, 40°C) 
CO2 conditions versus simple adsorption at 25°C.  Core-shell schematic is shown above the adsorption bar. 
Supercritical CO2 exposure increases Rhodamine B loading by ~100% over simple adsorption and 
subcritical CO2 exposure increases Rhodamine B loading by ~200% over adsorption.  *Significantly 
different from adsorption condition (p <.05) †Significantly different from PCL under same condition (p 
<.05) 
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4. Discussion 
4.1 Effects of CO2 infusion on nanofiber morphology and microstructure 
The capability of pressurized CO2 to plasticize polymers is well understood and 
frequently utilized as a processing technique in industry. Pressurized CO2 has recently 
gained interest within the research realm as a benign, green, and inexpensive technique to 
embed small molecules into polymer matrices.  As such, CO2 is an attractive vehicle for 
biomolecule infusion directed towards tissue engineering efforts.   Previous studies in our 
group [35] have shown varying biomolecule infusion and release behavior with 
alterations in pressure and phase of CO2.   Dense subcritical CO2 provides moderate 
plasticization, leading to some impregnation of biomolecules beneath the surface of a 
polymer matrix, enabling prolonged release.  Supercritical CO2 fully plasticizes the 
polymer material, embedding molecules deep within the matrix and enabling steady 
release.  Based on these properties of the different phases, our group has hypothesized 
that within core-shell scaffolds, subcritical CO2 infuses drugs into the shell region of the 
fiber, while supercritical CO2 can infuse drugs all the way into the core.  Both phases of 
CO2 melt most of the crystalline regions of polymers before swelling can occur.  
However, the swelling process increases free volume and chain mobility, allowing 
crystalline microstructure to reform and grow extensively during slow depressurization 
[36] .  This process is evident in XRD spectra (Figure 2), in which the crystalline peaks 
characteristic of PCL are more intense after infusion.  While microstructural changes 
during the infusion process are generally reversible, supercritical CO2 is so effective in 
swelling certain polymers, such as PCL, that it destroys the nanoscale scaffold 
morphology, potentially eliminating useful properties that depend on scaffold 
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microstructure [24, 37-41].  To prevent this phenomenon from damaging electrospun 
nanofibers and to preserve their valuable microstructure for tissue engineering 
applications, PCL is blended in equal parts with porcine gelatin.  Gelatin undergoes 
dehydration upon exposure to supercritical CO2, causing it to compress and prevent 
excessive PCL chain motion that would ordinarily denature nanofiber morphology [35].  
SEM imaging in Figure 1 shows evidence of nanofiber morphology both before and after 
supercritical CO2 exposure.  Interestingly, the core-shell nanofibers are unaffected by 
supercritical CO2 exposure even though the core is pure PCL.  The PCL-gelatin shell 
could conceivably protect the core by physically restraining it as it liquefies [42]. 
4.2 Hydrophobic-hydrophilic interactions and CO2-infused dye loading 
Interactions between drug and matrix play an important role in drug release 
kinetics, particularly in diffusion-based systems.  While PCL and blended PCL-gelatin 
are both biodegradable polymers, neither loses an appreciable amount of mass over the 
release period and therefore release from these scaffolds is governed solely by diffusion.  
Hydrophobic-hydrophilic interactions are an appealing target for investigation as they can 
be easily manipulated with drug selection, scaffold plasma treatment, and polymer 
blending [43].  Hydrophobicity differences between drug and scaffold should exert a 
profound but predictable effect on drug loading.  We observed that dyes infused into 
scaffolds with moieties of the same polarity experienced high loading, while the 
hydrophilic dye Rhodamine B exhibited reduced loading when infused into hydrophobic 
PCL.  Based on the high loading shown in Figure 7, it would appear that BODIPY still 
interacts strongly with a PCL-gelatin blend based on a 50% composition of hydrophobic 
PCL chains.  Loading of BODIPY was significantly greater than loading of Rhodamine B 
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under all conditions.  This is reasonable as the wash solution used was 70% ethanol in 
water, a very hydrophilic mixture.  This solvent was likely able to remove surface-bound 
Rhodamine B from the scaffold more effectively than BODIPY regardless of infusion 
condition.   
Almost twice as much Rhodamine B was loaded into scaffolds by infusion 
compared to adsorption.  BODIPY was loaded on average 45% more effectively by 
subcritical infusion versus adsorption.  CO2 infusion accomplishes this by plasticizing 
PCL, enabling impregnation of dye deeper into the polymer bulk.  CO2 infusion is 
therefore an effective tool to artificially introduce and control drug-matrix interactions 
within nanofiber scaffolds.  Surprisingly, loading was found to be higher for dyes when 
subcritically infused into core-shell scaffolds versus supercritically infused.  In its 
supercritical fluid phase, CO2 may be dissolving and leaching dye from the scaffolds 
during infusion.  This is plausible given the results of a study by  Zhao et al., which 
revealed increasing solubility of Rhodamine B with increasing pressure of CO2, as well 
as an intrinsically high solubility of nonpolar dyes like BODIPY in supercritical CO2 
[44].  
4.3 Hydrophobic-hydrophilic interactions and CO2 Infused dye release 
Similarly, hydrophobic-hydrophilic interactions between drug and scaffold affect 
release properties.  Previous literature suggests that stronger drug-matrix interactions 
allows for slower, more linear release while negative or lack of interaction promotes burst 
or rapid release [45].  BODIPY exhibited slow and limited release from all scaffolds, due 
to both a strong interaction with hydrophobic PCL domains found in all scaffolds as well 
as poor interactions with PBS as a release solvent.  Rhodamine B, on the other hand, 
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showed much faster release from hydrophobic PCL than hydrophilic PCL-gelatin, as 
evidenced by Figures 4(B), and 5(B).  Furthermore, comparison of Figures 4 and 5 shows 
that when two drugs were present, the drug with polarity similar to a given scaffold 
released more slowly and the drug with unlike polarity to a scaffold released more 
quickly. The release effect of interactions is further illustrated in Figure 3, where 
scaffolds initially infused with both dyes visibly retain only the ‘like’ dye after a 14 day 
infusion period.   
Infusion by CO2 embeds the drugs within the polymer bulk which necessitates 
interactions with the polymer chains before release can occur.  While PCL displayed a 
burst release of adsorbed Rhodamine B within 48 hours, this was reduced by nearly half 
when Rhodamine B was infused into PCL via subcritical CO2.   Interactions enacted by 
CO2 impregnation appear to have a more pronounced effect when infusing a hydrophilic 
dye into a hydrophobic scaffold or vice-versa [46].  A similar tactic for linearizing release 
was employed in a study by Yoon and Kim, wherein Rhodamine-releasing polyethylene 
oxide (PEO) nanofibers were embedded in mats of PCL nanofibers of varying thickness.  
In concordance with the results of our study, Yoon et al. found that  thicker layers of 
hydrophobic PCL reduced burst release and encourage slower, more linear release [32]. 
4.3.1 Interactions and CO2 infusion in core-shell scaffolds for multi-drug release 
Exposure to either sub- or supercritical CO2 plasticizes PCL and PCL-gelatin 
enough to allow infusion of model drug compounds either singly or in concert.  Even at 
subcritical pressures, polymer free volume is enhanced sufficiently to enable the greater 
mobility needed to allow for interdiffusion of these model drug compounds among the 
polymer chains and enhance the total loading above that created by either simple 
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adsorption or chemical attachment on high surface area nanofiber substrates. The greater 
intermolecular interactions of the hydrophobic PCL with BODIPY results in preferred 
partitioning of that compound within the PCL core.  Similarly, the greater intermolecular 
interactions of the hydrophilic gelatin with Rhodamine B results in preferred partitioning 
of that compound within the PCL-gelatin shell.  Using different phases of CO2 can 
further modulate drug localization in core-shell nanofibers, providing facile control of 
loading and release behavior.  Subcritical CO2 infusion induces preferred partitioning 
into the superficial shell while supercritical CO2 induces preferred partitioning into the 
core.   
Figure 6 displays very slow, linear release when BODIPY is infused into a PCL 
core with supercritical CO2 and when Rhodamine B is infused into a PCL-Gelatin shell 
using subcritical CO2.  Infusing BODIPY into the shell or Rhodamine B into the core 
leads to faster release while simple adsorption leads to a rapid initial burst of drug 
release.  These observations are consistent with the interaction-release relationship 
anticipated for these drug-matrix combinations and validate that CO2 infusion and drug-
matrix interactions can be effectively utilized to biofunctionalize electrospun nanofiber 
scaffolds and tailor the release profile of multiple biomolecules within such scaffolds.  
Past experiments with CO2 infusion have shown that supercritically infused dyes or drugs 
tend to display slower, steadier release than subcritically infused dyes.  This behavior was 
expected for both dyes when infused into core-shell fibers.  Interestingly, Figure 6 reveals 
that Rhodamine B released slower and steadier when subcritically infused into the shell 
compared to supercritically infused into the core.  These data support the hypothesis that 
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in CO2 infused nanofiber systems, interactions have a greater effect on release properties 
than phase of CO2.      
4.4 Applications in Tissue Engineering 
 Wound management requires an ECM-resemblant, fluid absorbing, gas 
permeable, non-adhesive dressing, making electrospun nanofibers an excellent fit for the 
demands of the condition [47].  Chronic wounds, however, require more than just a 
suitable scaffold.  Significant infection, underlying neuropathy and/or vascular 
degeneration must be addressed before substantial regeneration can occur.  This has been 
accomplished with some level of success by application of growth factors, such as PDGF, 
bFGF, and VEGF to the wound area [48].  However, topical application of drugs alone 
fails to realize their maximum potential [29] and high doses of these growth factors are 
known to increase the patient’s risk for cancer. Studies have also shown that unaddressed 
infection in chronic wounds greatly inhibits the healing process [48].  A CO2 infused 
nanofiber patch with controlled bimodal release capabilities provides a solution to this 
problem.  To immediately address infection, a small molecule antibacterial drug, like 
mupirocin, would be rapidly released from the scaffold.  Underlying pathology would be 
addressed by steady, long term release of a growth factor, which would peak in its 
cumulative release towards the end of the healing process.  Based on the results of this 
study, this could be accomplished using hydrophilic polymer nanofibers, with 
hydrophobic mupirocin infused subcritically and hydrophilic PDGF infused 
supercritically.    
5. Conclusions 
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Electrospun nanofibers are promising materials for tissue engineering 
applications, especially chronic wounds.  CO2 infusion technology can further augment 
nanofiber biomaterials by incorporating bioactivity through growth factors and other 
biomolecules.  CO2 infusion holds advantages over other methods for drug infusion in 
that it is an inexpensive, green, and bioactivity-preserving vector for impregnation.  This 
study used dyes to provide a better understanding of the effects of hydrophobic-
hydrophilic interactions within CO2 infused nanofiber systems.  This type of drug-matrix 
interaction should be strong in order to elicit long-term, linear release but weak if the goal 
is to elicit rapid burst release of drug.  CO2 infusion provides an approach to engineer 
such strong interactions and achieve desirable release profiles by embedding different 
drugs within the nanofiber scaffold.  In particular, biphasic core-shell nanofiber scaffolds 
can achieve an even greater level control over release using different phases of CO2 to 
partition drugs within composite scaffolds.  Future work will capitalize on this high level 
of control to build a core-shell nanofiber scaffold capable of bimodal release of two 
biomolecules relevant to chronic wound healing.  
5.1 Future Work 
Ultimately, our group intends to utilize the preferred partitioning effects of the 
different phases of CO2 in core-shell nanofibers to design drug-matrix interactions for a 
target release profile.  Bimodal release is of particular interest to us for applications in 
tissue engineering.  From a nanofiber patch, a small molecule drug could be released 
immediately while a larger, protein based therapeutic would be released steadily over 
time, peaking in cumulative release towards the end of treatment.  Previous studies within 
the group have shown a significant, yet uncharacterized, effect of infused particle size on 
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release properties from CO2 infused nanofiber scaffolds.  Before clinically focused 
studies with protein based drugs can be conducted, this effect must be better understood.  
Current work is focused on a pilot study on this effect.  In a factorial experimental design, 
Rhodamine B (2 nm hydrodynamic diameter), Green Q-Dots (4 nm hydrodynamic 
diameter), and FITC-labeled bovine serum albumin (7 nm hydrodynamic diameter), will 
be subcritically infused into PCL nanofibers with or without air plasma treatment (to 
account for surface hydrophilicity).  Each size-plasma treatment condition will be run 4 
times for a total of 24 runs.  We expect to observe either a linear relationship between 
particle size and release properties, or possibly a size cutoff at which subcritical CO2 
infusion does not affect release properties.  Data acquired from this study will be useful 
in development of the CO2 infused nanofiber system towards controlled release of 
clinically relevant compounds. 
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Appendix 
 
Figure A1: Fluorescence images of dual dye infused (subcritical condition) PCL (left) and PCL-gelatin 
(right) scaffolds after 14 days of release.  A) GFP filter detecting BODIPY B) RFP filter detecting 
Rhodamine B.  One can visibly notice differences in Rhodamine dye fluorescence between PCL (unlike) 
and PCL-gelatin (like) scaffolds. 
 
A 
B 
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 Figure A2: Factorial design to screen factors of particle size, surface hydrophilicity (as induced by plasma 
treatment and a bit different than material hydrophilicity), and their interaction in future work with CO2 
infused nanofiber systems. 
Table A1: Experimental design for the project.  Note that supercritical infusion into PCL is not possible; 
the PCL nanofibers will melt and lose their microstructure.  This rendered supercritical infusion into PCL-
gelatin less useful, since one could only observe like interactions for Rhodamine B and unlike interactions 
for BODIPY in the supercritical infusion state.  Core-shell design was decided upon after the results in 
Figures 4 and 5 were analyzed.   
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